Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of toll-like …

J Dai, Y Wang, H Wang, Z Gao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Toll-like receptors (TLRs) are key sensors that recognize the pathogen-associated
molecular patterns (PAMPs) of severe acute respiratory syndrome coronavirus 2 (SARS …

Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: In …

YO Ayipo, I Ahmad, YS Najib, SK Sheu… - Journal of …, 2023 - Taylor & Francis
The nsp3 macrodomain and nsp12 (RdRp) enzymes are strongly implicated in the virulent
regulation of the host immune response and viral replication of SARS-CoV-2, making them …

Extracellular vesicle associated miRNAs regulate signaling pathways involved in COVID-19 pneumonia and the progression to severe acute respiratory corona virus …

AS Meidert, S Hermann, F Brandes, B Kirchner… - Frontiers in …, 2021 - frontiersin.org
Background Extracellular vesicles (EVs) are mediators of cell-to-cell communication in
inflammatory lung diseases. They function as carriers for miRNAs which regulate mRNA …

Role of angiotensin II in cardiovascular diseases: Introducing bisartans as a novel therapy for coronavirus 2019

J Swiderski, LK Gadanec, V Apostolopoulos, GJ Moore… - Biomolecules, 2023 - mdpi.com
Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

Protein subunit vaccines: Promising frontiers against COVID-19

VP Chavda, ENHK Ghali, PC Balar… - Journal of Controlled …, 2024 - Elsevier
The emergence of COVID-19 has posed an unprecedented global health crisis, challenging
the healthcare systems worldwide. Amidst the rapid development of several vaccine …

Dendritic cell-based vaccine: The state-of-the-art vaccine platform for COVID-19 management

VP Chavda, AB Patel, LK Vora… - Expert review of …, 2022 - Taylor & Francis
Introduction A correlation between new coronaviruses and host immunity, as well as the role
of defective immune function in host response, would be extremely helpful in understanding …

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies

H Ridgway, GJ Moore, LK Gadanec, A Zulli… - Expert Opinion on …, 2024 - Taylor & Francis
Background Hypertension worsens outcomes in SARS-CoV-2 patients. Sartans, a type of
antihypertensive angiotensin receptor blocker-(ARB), reduce COVID-19 morbidity and …

Inhalable vaccines: Can they help control pandemics?

VP Chavda, LK Vora, V Apostolopoulos - Vaccines, 2022 - mdpi.com
The emergence of a new coronavirus presents a huge risk to public health worldwide and
has spread widely amongst the human population. Since its emergence, the severe acute …